Navigation Links
United BioSource Scientist Leads Development of New Guidelines for Drug Reimbursement by German Government
Date:2/19/2008

New Methods Delivered to German Government in January

BETHESDA, Md., Feb. 19 /PRNewswire/ -- United BioSource Corporation's (UBC) director of global health economics has just delivered to the German government one of the most significant revisions of drug policy produced in Europe in more than a decade.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070910/NEM007LOGO )

The 70-page report, commissioned last year by Germany's Institute for Quality and Efficiency In Healthcare (IQWiG), will be used by the German government to evaluate drugs and devices and to set prices and reimbursement levels for those products. The document is expected to be widely influential both inside and outside of Germany, the third largest pharmaceutical market in the world.

The director and main author of the report, Jaime Caro, MD, Senior Vice President of UBC, was selected by the German government to head the eight- member international panel because of his recognized authority in the design and implementation of cutting-edge modeling and analytic techniques for health technology assessments, particularly in determining the value and safety of medical products.

According to Dr. Caro, "It was an immense honor to lead such a distinguished panel in developing pioneering methods for economic evaluation. These methods will have a strong influence on the efforts of society to control health care costs. I am very glad that with my team of experienced professionals at UBC, we can work towards improving health outcomes."

Made public in Berlin on January 24, 2008 by IQWiG, the findings and recommendations of the expert panel, if accepted, will directly impact the pricing and reimbursement of pharmaceuticals, biologicals and medical devices in Germany, which has the largest population of any EU nation.

Dr. Caro recommends that companies with marketed products and products in development set up a process to assess where the pharmaceuticals fall under the new methods and "be prepared to defend their position, understanding that they might need additional data or other strategies."

The report is titled Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System.

United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.

UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Western Europe (including Cologne, Germany), Eastern Europe and South America. For more information, visit http://www.unitedbiosource.com or call 866-458-1096.

CONTACT: Tess Drahzal, +1 (240) 644-0420, info@unitedbiosource.com
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Jaime Caro, MD http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=73597


'/>"/>
SOURCE United BioSource Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. His Royal Highness The Duke of York Helps Launch UK-Based Pharmaceutical Company, ProStrakan, in the United States
2. Davis Vision, United Concordia Free Clinic Promotes Childrens Eye and Dental Health
3. United Concordia Celebrates National Childrens Dental Health Month
4. UnitedHealthcare of the River Valley Acts to Help Tennessee Victims of Storm Devastation
5. Access Is Not Enough: What It Will Take to Transform Health Care in the United States
6. United Concordia Unveils New Online Capabilities for Producers
7. USP publishes Spanish edition of United States Pharmacopeia and National Formulary
8. MedWaves, Inc. Announces Receipt of United States Food and Drug Administration 510k Clearance to Market Its Patented Microwave Coagulation/Ablation System
9. Peninsula United Methodist Homes Completes Enterprise-Wide Deployment of AccuNurse Voice-Assisted Care
10. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
11. United States Joins False Claims Act Cases Against Three New Jersey Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 2016 , ... Dickinson Insurance & Financial Services continues their commitment to act ... of a local boy named Barrett, who has been fighting ALL leukemia for almost ... support for, all local families dealing with childhood cancer. Information on how to help ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hoggan ... force gauges used in physical therapy, occupational therapy and sports medicine clinics, hospitals, ... cord exercise and therapy, introduces its new microFET Digital Pinch Gauge. , ...
(Date:2/11/2016)... ... ... As part of their 2015 end of year funding strategy, Colleen’s ... gifted $10,000 to University of Chicago to support ovarian cancer research being conducted by ... honored to support a promising young investigator from Dr. Lengyel’s lab at the University ...
(Date:2/10/2016)... ... ... LaserShip, a regional parcel carrier that services the eastern U.S., donated and ... in order to aid in the Flint water crisis. In 2014, LaserShip acquired Prestige ... Clio, only 15 miles away from Flint. , “We have deep roots in the ...
(Date:2/10/2016)... ... 10, 2016 , ... InDemand Interpreting , a leading ... with Heart City Health Center to improve access to language services ... Health Center has provided the Elkhart community with access to high quality, affordable ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... MEMPHIS, Tenn. , Feb. 11, 2016 ... a promising new treatment method at West Cancer ... low intensity electric fields to inhibit cancer cell replication ... therapy in more than a decade to show a ... adult Glioblastoma Multiforme (GBM) patients. Currently, West Cancer Center ...
(Date:2/11/2016)... 11, 2016 --> ... new research report, titled "Sports Medicine Devices Market - Global ... 2019". According to the report, the global sports medicine devices ... 2013 to 2019, growing from a value of US$6.1 bn ... --> --> The global sports medicine devices ...
(Date:2/11/2016)... NORTH CHICAGO, Ill. , Feb. 11, 2016 ... launch of the AbbVie Rheumatology Scholarship, designed to ... a rheumatologic disease as they pursue higher education ... $15,000 each for the 2016-2017 school year. The ... Tracie Haas , vice president, corporate ...
Breaking Medicine Technology: